Maxine Ajimi

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• AstraZeneca (United Kingdom)14.4%
• European Institute of Oncology11.1%
• AstraZeneca (Brazil)10%
• Eli Lilly (United States)7.8%
• University of Milan7.8%
• Dana-Farber Cancer Institute7.8%
• Other41.1%

Fields

• Biochemistry, Genetics and Molecular Biology50%
• Medicine50%

Topics

• Advanced Breast Cancer Therapies31%
• HER2/EGFR in Cancer Research15.5%
• Estrogen and related hormone effects15.5%
• Breast Cancer Treatment Studies12.1%
• Cancer Treatment and Pharmacology5.2%
• Cancer-related Molecular Pathways3.4%
• Other17.2%